2003
DOI: 10.1001/archneur.60.9.1245
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Focal Cerebral Infarctions on Lesional RhoA and RhoB Expression

Abstract: Inhibition of Rho is a promising lead for the development of new pharmacologic interventions in FCI. Because the observed up-regulation of RhoA and RhoB was still detectable months after FCI, we speculate that even delayed treatment with Rho inhibitors might be a therapeutic option.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
29
0

Year Published

2004
2004
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 36 publications
(31 citation statements)
references
References 20 publications
2
29
0
Order By: Relevance
“…Similar increases in RhoA protein levels previously have been reported in stroke brain sections and in various cellular components of rodent cerebrovasculature after exposure to global ischemia. 8,9 In the latter study, suppression of neuronal RhoA levels via hyperbaric oxygen confirms the ability of ischemia to regulate GTPase expression. 9 Consistent with increases in Rho kinase protein levels, cells exposed to OGD also possessed higher levels of Rho kinase activity.…”
Section: Discussionsupporting
confidence: 52%
“…Similar increases in RhoA protein levels previously have been reported in stroke brain sections and in various cellular components of rodent cerebrovasculature after exposure to global ischemia. 8,9 In the latter study, suppression of neuronal RhoA levels via hyperbaric oxygen confirms the ability of ischemia to regulate GTPase expression. 9 Consistent with increases in Rho kinase protein levels, cells exposed to OGD also possessed higher levels of Rho kinase activity.…”
Section: Discussionsupporting
confidence: 52%
“…Furthermore, the involvement of RhoB in programmed cell death (Liu et al, 2000) may occur via activation of mDia2 (Kamasani et al, 2007). Indeed, RhoB is emerging as a key player in CNS injury (Brabeck et al, 2003(Brabeck et al, , 2004 and aging (Yoon et al, 2007). Evidence that RhoB modulates Alzheimer's diseaserelated genes suggests a link between this GTPase and dementia (Kamasani and Prendergast, 2005).…”
Section: Introductionmentioning
confidence: 99%
“…Understanding the signaling mechanisms of ROCK inhibition mediated NOG opens up the possibility for developing novel strategies to promote axon regeneration in vivo. Clinically, the use of a ROCK inhibitor may be useful for developing therapies in CNS following damage by Alzheimer's disease [44], spinal cord injury [45], traumatic brain injury [46] and stroke [47].…”
Section: Discussionmentioning
confidence: 99%